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Abstract
Background: Prevention of multi-morbidities following non-communicable diseases requires a systematic
registration of adverse modifiable risk factors, including low physical fitness. The aim of the study was to establish
criterion validity and reliability of a smartphone app (InterWalk) delivered fitness test in patients with type 2
diabetes.
Methods: Patients with type 2 diabetes (N = 27, mean (SD) age 64.2 (5.9) years, BMI 30.0 (5.1) kg/m2, (30 % male))
completed a 7-min progressive walking protocol twice (with and without encouragement). VO2 during the test was
assessed using indirect calorimetry and the acceleration (vector magnitude) from the smartphone was obtained.
The vector magnitude was used to predict VO2peak along with the co-variates weight, height and sex. The validity
of the algorithm was tested when the smartphone was placed in the right pocket of the pants or jacket. The
algorithm was validated using leave-one-out cross validation. Test-retest reliability was tested in a subset of
participants (N = 10).
Results: The overall VO2peak prediction of the algorithm (R
2) was 0.60 and 0.45 when the smartphone was placed
in the pockets of the pants and jacket, respectively (p < 0.001). The mean bias (limits of agreement) in the cross
validation was−0.4 (38) % (pants) and−0.1 (46) % (jacket). When the smartphone was placed in the jacket a
significant intensity dependent bias (r = 0.5, p = 0.02) was observed. The test-retest intraclass correlations were
0.85 and 0.86 (p < 0.001), for the pants and jacket, respectively. No effects of encouragement were observed on
test performance.
Conclusion: In conclusion, the InterWalk Fitness Test is accurate and reliable for persons with type 2 diabetes when
the smartphone is placed in the side pocket of the pants for. The test could give a fair estimate of the CRF in
absence of a progressive maximal test during standardized conditions with the appropriate equipment.
Trial registration: www.clinicaltrials.org (NCT02089477), first registered (prospectively) on March 14th 2014
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Background
Type 2 diabetes (T2D), along with a range of non-
communicable diseases, has become an increasing soci-
etal burden [1–3]. Low cardiorespiratory fitness (CRF) is
a marker of low health-related physical activity [4, 5]
and an independent predictor of some of these non-
communicable diseases including T2D and all-cause
mortality [6–8]. Modifiable risk factors, such as low
CRF, should be identified and targeted in order to imple-
ment strategies to prevent the development and conse-
quences of these diseases. CRF is normally assessed in
the laboratory by a comprehensive exercise test with ex-
pensive equipment, administered by trained test personnel
and with the requirement of maximal effort from the
participants. Hence, this procedure is not appropriate and
feasible in populations selected for large scale testing. A
number of field-applicable walking/running-based test
protocols have been developed and tested [9]. Although
criterion validity has been established for these protocols,
they still require the presence of test personal, standard-
ized surroundings, post processing and reporting of test
results which makes them difficult to apply in large-scale
testing and monitoring within clinical care and rehabilita-
tion. Thus, novel low cost and valid methods to assess
VO2peak can improve the detection of people at risk and
increase the use of VO2peak as a risk stratification tool.
On-board movement sensors on smartphones allow
for registration of exercise intensity. With the increasing
use of smartphones, this platform might thus be a feas-
ible tool for estimating CRF on a larger scale. Since new
more feasible test for large scale testing and monitoring
are needed we developed a smartphone delivered progres-
sive walking CRF test for persons with T2D, as walking is
considered safe and feasible, not least for the elderly popu-
lation [10].
The aim of the study was to establish criterion validity
and test-retest reliability of a 7-min progressive sub-
maximal CRF test delivered by the smartphone app Inter-
Walk. Secondarily, we aimed to examine the importance
of the body location of the smartphone (the side pocket of
the pants or jacket), and of therapist encouragement
during the test on test performance.
Methods
Study sample
The present article describes a validation study that is a
subset of a trial investigating the effect of SMS-prompting
on the adherence to IWT (NCT02089477). Participants
were recruited using bulletins. Potential participants
contacted the project employees by telephone and were
orally informed about the study. If no exclusion criteria
(see below) were identified through the telephone inter-
view, written material and consent form was mailed to the
participant and participants was offered an information
meeting. Interested participants screened by telephone was
examined at a pre-examination and further informed about
the study.
The inclusion criteria were; confirmed T2D diagnose
(fasting glucose ≥7.0 mmol/L, random measured
glucose ≥11.1 mmol/L, 2 h oral glucose tolerance test
glucose ≥11,1 mmol/L or HbA1c > 48 mmol/mol),
age˃30 years and BMI ˃18 but ˂40. Exclusion criteria in-
cluded pregnancy, insulin dependence, contraindications
to physical activity and any evidence of thyroid, liver,
lung, heart or kidney disease [11]. Training status was
not an in or exclusion criteria, however participant in-
cluded were characterized with low physical fitness
(VO2max/kg = 23,3 (±4,6) ml O2/kg/min) [12]. The sam-
ple for this validation study constitutes of participants
with available data on VO2peak and smartphone sample
accelerometer data. No formal sample size calculation
was therefore performed. The participants had either
no or 3 months’ experience with the InterWalk app.
Participants received oral and written information
about the study and informed consent was obtained
from all participants. The study is approved by the
Regional Ethics Committee of the Capital Region of
Denmark (H-1-2013-116).
The Inter Walk app
The development of the InterWalk app and the back-
ground for development has been described in details
elsewhere [13]. Briefly, the InterWalk app was developed
as a vehicle to deliver interval walking training (IWT)
for persons with T2D. The intensities during IWT are in-
dividualized based on the InterWalk Fitness Test
(IWFT)-a standardized 7-min progressive walking test
protocol (see below). During IWT and IWFT, on-board
accelerometer data are sampled (100 Hz). The vector
magnitude (VM) is calculated as the square root of the
summed squared acceleration from the x, y and z axes.
Subsequently, the data are averaged across 30 s. The
data are transmitted to the server through Wi-fi or the
mobile data network along with user demographics and
central personal registration number [14].
Procedures
Indirect calorimetry (described below) was used as the
criterion measure to validate the prediction of VO2peak
from the accelerometer data obtained during the IWFT
along with other co-variates. To establish test-retest reli-
ability, the IWFT was repeated after 1 week in a subset
of the participants (N = 10). Prior to testing, all partici-
pants underwent a medical screening including a health
status interview and a physical exam, and demographic
information was obtained.
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The Inter Walk Fitness test (IWFT)
The IWFT protocol consists of 2 minutes of slow,
followed by 2 minutes of intermediate, 2 minutes fast and
1 minute of very fast walking. The walking intensities are
self-selected, thus what “slow walking”, “fast walking” etc.
means is defined by the user. The test protocol is audio
guided through earphones. Hence, the app automatically
instructs the user to start and change the walking inten-
sities as described above.
After a thorough introduction to the test procedures
and the InterWalk app, the participants completed two
IWFTs during each visit (see below). The tests were ad-
ministered by smartphones (Iphone 5C, IOS 7, v 1.18.8/
2.0, Apple inc). All IWFTs were performed outside on a
standardized course. The course was selected to reflect a
free-living situation; i.e. the tests were performed on a
side-walk near a major road (incl. traffic noise and other
pedestrians) with turns and varying surface.
The first IWFT was self-administered with self-selected
pace, performed only by the auditory instructions from
the InterWalk app. The second test was conducted with
self-selected pace by instruction from the InterWalk app
along with verbal encouragement from the examiner to
increase the subjects’ walking intensity during the last mi-
nute of the test. At both IWFTs the smartphones were
placed in the right side pocket of the pants (lower pos-
ition; LP) and in the right side pocket of the jacket (upper
position; UP) (Fig. 1). A resting period of >20 min was
employed between the two tests.
Measurement of peak (VO2peak) and maximal oxygen
consumption (VO2max)
VO2peak was assessed during both IWTF procedures using
indirect calorimetry (Cosmed K4b2, Cosmed, Italy) as in-
direct calorimetry is considered the gold standard in
assessing VO2 in a clinical setting [15]. The device is a
lightweight portable system calculating oxygen uptake
from breath by breath measurements described in detail
elsewhere [16] and has previously been validated [17]. The
system was calibrated according to the manufacturer
description. VO2peak was defined as the mean oxygen con-
sumption (ml O2) during the last 30 s of the protocol.
VO2max was assessed by a graded walking test proto-
col on treadmill (Technogym Runrace, Gambettola,
Italy). Since the majority of the participants don’t have
the capacity to run, the walking test protocol was
chosen. This test has previously been used successfully
in our laboratory [18]. The participants were allowed to
select their own comfortable walking speed ranging
from 1.6 to 4.8 km/h at a 1 % incline during a 6-min
warm-up. The warm-up was followed by 2 min inter-
vals of increasing inclines (2 % per stage) at individually
determined brisk walking, ranging from 2.2 to 5.5 km/h
until two of the three following criteria were met:
plateauing of VO2 with incremental workloads and/or
respiratory exchange ratio 1,0 and/or at exhaustion
(as assessed by the examiner). Oxygen consumption
was assessed using continuous indirect calorimetric
measurements (CPET, Cosmed, Italy).
a b
Fig. 1 Photo of placements and setup. 1a: Smartphone placed in the side pocket of the pants (lower position, LP), 1b: Smartphone placed in the
side pocket of the jacket (upper position, UP)
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Anthropometry
Height and weight were determined using standard proce-
dures. Height was measured barefooted to the nearest
0.1 cm by a stadiometer (The Leichester Height Measure,
Tanita). The weight was assessed during dual-energy X-
ray absorptiometry scan (Lunar Prodigy Advance; GE
Healthcare, Madison, WI).
Prediction of VO2peak during the IWFT
Tri-axial accelerometry has previously shown to predict
energy expenditure (EE) during walking when the monitor
was attached to the body [19–22]. Thus, the on-board ac-
celerometer of the smartphone was used as predictor of
VO2peak during the IWFT. The remaining predictor vari-
ables were chosen a priory. As EE increases during walk-
ing with higher body weight and height, these parameters
were included as co-variates in the prediction model along
with sex [23]. We chose not to include other predictor
variables due to consideration of feasibility, as the users of
the InterWalk app provide this information during set up
of the InterWalk app [13]. As the relationship between
VO2 and acceleration has previously been shown to be
linear during walking [19–22], we chose to build our pre-
diction model using a linear regression model as described
below;
Y i ¼ β0 þ β1Xi1 þ β2Xi2 þ β3Xi3 þ β4Xi4 þ εi ð1Þ
Where Yi is VO2peak (ml/min) during the last 30 s. of
the test, Xi1 is the mean VM (g) during the last 30 s of
the test, Xi2 is the body weight, Xi3 is the body height
(cm), Xi4 is a sex indicator (0 for women, 1 for men) and
εi is the error term. Standard linear regression diagnos-
tics, including examining linearity, homoscedasticity,
multi-collinearity and normal distribution of the resid-
uals were performed. No indications of violations of the
linear regression assumptions of the prediction equa-
tions were observed.
Statistical analyses
To established criterion validity we correlated the prod-
uct–moment correlation coefficient (r) between the VM
and oxygen consumption [24]. In order to obtain an
un-biased estimate of the precision and accuracy of the
predicted VO2peak, we calculated the predicted VO2peak
using the leave-one-out cross validation (LOOCV).
Agreement between the predicted values from the
LOOCV and the observed values are evaluated using
Bland-Altman plots with mean bias and limits of agree-
ment (LOA) [25].
Reproducibility (test-rest) was expressed as the intra-
class correlation coefficient (ICC) of the predicted values
across 1 week. The interpretation of the reproducibility
was based on the size of the ICC and classified as good
to excellent (1.00–0.76), fair to good (0.75–0.41) and
poor (0.41–0.00) [26]. Furthermore, we calculated the
minimal detectable change (MDC) not due to measure-
ment error of the predicted VO2peak. The MDC was
calculated as 1.96*√2*(Standard deviationMD (1week follow-
up and baseline)/√2) [27, 28]. All analyses were performed
using STATA IC 13.1 (Stata Corp, Texas, USA).
Statistical significance was set at α˂ 0,05 (two tailed).
Results
Sample characteristics
A total of 27 participants (31 % with previous InterWalk
app experience) completed the protocol. Sample charac-
teristics are described in Table 1. Participants with and
without previous experience with the InterWalk app did
not differ in VO2max and VO2peak. However, participants
with previous experience were heavier (MD [95 % CI])
(12.1 kg [1.0;23.1]), had a higher BMI (4.1 [0.5;7.5]) kg/
m2 and a higher HbA1c (ratio of geometric mean [95 %
CI] 1.11 [1.08;1.16]). The participants reached (mean
[95 % CI]) 85 % [79.0 to 90.0] of their VO2max during
the IWFT.
Effects of encouragement and placement of the
smartphone on VO2peak and vector magnitude
Table 2 describes the observed VO2peak and VM during
the last 30 s of the 7-min IWFT. No difference in
VO2peak was observed when the test was completed with
encouragement compared with completion without en-
couragement (p = 0.70). Nor did the VM differ between
tests (p = 0.40 and 0.12 for differences between encour-
agement and no encouragement, when the smartphone
was placed in the LP and UP, respectively). However, a
lower VM was observed when the smartphone was placed
in the UP, compared to the LP, when the test was per-
formed without (MD [95 % CI]) (−0.17 G [−0.22;−0.11])
as compared to encouragement (MD [95 % CI]) (−0.18 G
[−0.23;−0.12]).
Accuracy and precision of the predicted VO2peak
The correlations between VO2peak and VM during the
last 30 s of the test for the LP and UP are depicted in
Fig. 2. Data from the tests with and without encourage-
ment were pooled as no differences between the r-values
were observed between the LP (rencouragement [95 % CI] =
0.63 [0.33;0.82], rno encouragement [95 % CI] = 0.54
[0.20;0.76]) or the UP (rencouragement [95 % CI] = 0.31
[−0.08;0.63], rno encouragement [95 % CI] = 0.42 [0.05;0.70]).
To account for the repeated measurements in the pooled
analysis, we adjusted the standard errors for within-
participant clustering (using VCE cluster option, Stata IC
13). The regression equation for prediction of VO2peak
during the last 30 s. of the 7-min IWFT for the LP was
described as;
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VO2peak ¼ 1853  VM Gð Þ þ 11:8  weight kgð Þ þ 25:2  height cmð Þ
– 615:5  sex 0 f or women; 1 f or menð Þ
– 4006 2½ ; r2 ¼ 0:60; p < 0:001
ð2Þ
And for the UP as;
VO2peak ¼ 2379  VM Gð Þ þ 15:0  weight kgð Þ þ 11:3  height cmð Þ
– 77:8  sex 0 f or women; 1 f or menð Þ
– 1901; r2 ¼ 0:45; p < 0:001
ð3Þ
Figure 3 describes the accuracy and precision of the
predictions algorithms for the LP (Fig. 3a) and for the
UP (Fig. 3b) from the leave-one-out cross validation.
The precision was [LOA ± 46.8 %] for the UP and [LOA
± 35.5 %] for the LP.
Reliability and the minimum detectable difference of the
predicted VO2peak
The reliability (ICC [95 % CI)]) was 0.86 [0.64; 0.96] of the
predicted VO2peak for the LP. For the UP the reliability
(ICC [95 % CI)]) was 0.85 [0.60; 0.96]. The MDC was
298 ml O2 for the LP and 203 ml O2 for the UP.
Prediction of VO2max
The predicted VO2peak correlated with the measured
VO2max (rLP = 0.70, p < 0.001 and rUP = 0.56, p = 0.004).
The predicted VO2peak underestimated the VO2max by
15.5 % (p < 0.001) for the LP and 14.2 % (p < 0.001) for
Table 1 Sample characteristics
Total Men Women
N 27 9 18
Age (years) 64.2 (5.9) 65.9 (6.8) 63.3 (5.5)
Level (no exp./previous exp.) 16/11 5/4 11/7
Time since T2D diagnosis 7.9 (5.0) 8.3 (5.3) 7.6 (4.9)
Body weight (kg) 83.2 (14.9)* 90.0 (13.4) 79.7 (14.7)
Body height (cm) 166.6 (7.7)* 175.2 (4.0) 162.2 (4.7)
Body mass index (kg/m2) 30.0 (5.1) 29.3 (4.9) 30.3 (5.3)
HbA1c (mmol/mol) 47.0
[41.0;57.0]
49.0 [45.0;
57.0]
47.0
[38.0;50.0]
HbA1c (%) 6.4 [5.9; 7.4] 6.6 [6.3; 7.4] 6.4 [5.6; 6.7]
Anti-diabetic medication
(yes/no))
23/4 6/2 16/2
VO2max(ml/min) 1940 (457)* 2314 (427) 1773 (369)
Relative VO2max(ml/kg/min) 23.3 (4.6) 25.3 (4.6) 22.5 (3.9)
Data are mean (standard deviation) or median [Inter quartile range], HbA1c;
Glycated hemoglobin A1c. Sex differences (* p < 0.05) were tested using student’s
t-test for normally distributed variables and Wilcoxson’s rank sum test for non-
normally distributed variables
Table 2 VO2peak and vector magnitude during the last 30 s of
the walking test
VO2peak
(ml/min)
Vector magnitude
(LP) (G)
Vector magnitude
(UP) (G)
N 27 27 27
No encouragement 1602 (427) 0.30 [0.22;0.46] 0.17 [0.14;0.20]*
Encouragement 1651 (436) 0.39 [0.25;0.51] 0.19 [0.14;0.24]*
Data are means (standard deviation) or medians (interquartile range). *p < 0.001
for differences between body positions, LP; lower position, smartphone placement
in the right side pocket of the pants, UP; Upper position, smartphone placement in
the right side pocket of the jacket. Differences were tested using Wilcoxon’s
matched-pair signed-rank test
y = 1537x, r = 0.59, p<0.001
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Vector magnitude (G) during the last 30 seconds of the test
Fig. 2 The partial correlations between VO2peak and vector
magnitude during the last 30 s of the test when the smartphone
was placed in the lower position, smartphone placement in the
right side pocket of the pants (Panel a) and in upper position,
smartphone placement in the right side pocket of the jacket (Panel
b). The dotted line is the best fit line. Triangles (▲) represent
observations during the test with encouragement and crosses (X)
are observations during the test without encouragement. The grey
shaded area is the 95 % confidence interval
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the UP. The mean bias [LOA] was 308 [215 to 401] ml
O2 for the LP and 272 [118 to 427] ml O2 for the UP.
The equations for both positions (LP and UP) underesti-
mated the VO2max for participants with higher VO2max
values and underestimated for the participants with
lower values. The correlation between the bias and the
mean of the VO2max and the VO2peak values was r = 0.36
(p < 0.01) for the LP and r = 0.46 (p < 0.02) for the UP.
Discussion
The aim of this study was to present a VO2peak protocol
delivered by a smartphone app (InterWalk) and to
establish criterion validity and test-retest reliability of a
7-min progressive fitness test. In addition we examined
whether validity was influenced by the body location of
the smartphone and if the test performance was affected
by therapist encouragement. The accuracy and precision
of the predicted VO2peak were dependent on body loca-
tion, i.e. higher when the smartphone was placed in the
LP. Furthermore, encouragement during the last minute
of the test did not seem to affect test performance in this
sample.
Differences between body locations
The VO2peak was predicted with a high accuracy for both
body locations (LP and UP) along with comparable
reliability. However, when the smartphone was placed in
the UP, the VO2peak was overestimated at the higher
intensities and underestimated at the lower intensities
and the LOAs were wider. The partial correlation coeffi-
cients revealed that the algorithm was less dependent on
the only dynamic test parameter in the algorithm (VM)
for the UP compared to the LP and the recorded
acceleration was generally lower. This would make the
prediction algorithm less sensitive to variation herein.
Differences in the validity for predicting VO2 between the
placements of the accelerometer-based physical activity
monitors are consistent with previous studies [29–31].
When the smartphone was placed in the UP, the acceler-
ometer is closer to the centre of mass as observed when
accelerometers are fixed on the hip or lower back. In con-
trast to the use of research physical activity monitors, the
type of jackets, worn by the participants in the present
study, was not standardized. Thus, some participants wore
loosely fitted jackets and others wore jackets more closely
attached to the body, all with different size pockets. The
lower accuracy and higher variation of the IWFT when
the smartphone was placed in the UP, might be due to
movements of the jacket not corresponding to the actual
movement of the body and therefore induce measurement
error. When the smartphone was placed in the LP the
accelerometer where close to the thigh/hip following the
movement of the leg during walking closely and thus, the
measurement error would be lower, explaining the nar-
rower LOA for the LP. As the acceleration is the only
body movement intensity-dependent variable in the equa-
tion, it could be speculated that the underestimation at
higher VO2peak values is due to low sensitivity to capture
the body acceleration. If increases in the observed acceler-
ation on the smartphone either do not reflect or under-
estimate the concomitant acceleration in body, i.e. centre
of mass, an underestimation would be observed at higher
intensities. However, we did not measure the actual accel-
eration of the body during this study. The acceleration
signal was un-filtered, i.e. all movement frequencies of the
smartphone were included. The VM used in the IWFT
was calculated as an average across a 30 s. epoch, and
thus would suppress high frequency noise components to
some extent. It is possible that high and low frequency
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Fig. 3 The accuracy (mean bias) and precision (±1.96 Standard
deviation (SD)) of the VO2peak prediction algorithms for the lower
(panel a) and the upper (panel b) position of the smartphone
placement in the ‘leave-on-out cross validation’. The dotted line is
the best fit line and represents the bias of the predicted values.
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acceleration components, not related to body movement
per se, could explain the low precision of the estimates
across both body locations.
Several field-based walking tests have been developed
and validated. In a recent meta-analysis Mayorga-Vega
et al. (2016) reported low-to-moderate (r = 0.42–0.79)
criterion-related validity for walk/run field tests to esti-
mate VO2max across 123 studies [9]. This is comparable
to the IWFT, when the smartphone was placed in the
LP. However, the studies reported on did not include pa-
tients. When compared to the criterion validity for the
commonly used six minute walking test (6MWT) in pa-
tient groups characterized with low VO2peak, the
criterion-related validity was slightly better for the IWFT
[32, 33].
Clinical feasibility
The performance during field-based walking tests may
be affected by encouragement from test personnel, in-
creasing the resources needed to implement them in
clinical care. [33, 34]. Differences in walking distance
have been observed in elderly people [32, 33, 35] and in
patients with pulmonary limitations [36, 37] when the
6MWT is performed repeatedly. No differences in
VO2peak were observed, neither when the IWFT was per-
formed self-conducted, nor with encouragement during
the test. In view of the similar performance with and
without encouragement and the high reproducibility
(ICC; LP 0.86 and UP 0.85), the IWFT can be performed
without the presence of professional test personnel,
which will increase feasibility of the test in clinical and
rehabilitation programs. Moreover, the high reliability
indicates that the test has a very high consistency across
from one test administration to the next [38], making it
feasible to implement. The MDC not due to measure-
ment error indicates the sensibility of the measurement
to detect a change in the parameter of interest. Thus,
the MDC indicates that the IWFT is able to detect
changes in VO2 larger than ±18 % and ±13 % for the LP
and UP, respectively. The exercise-induced magnitude of
improvements in fitness level is related to the initial
fitness level. Thus, only small changes (~5%) in CRF are
observed in well trained individual (VO2max ≥ 3500 ml
O2/min) with training programs of high intensity [39, 40].
In contrast high intensity exercise interventions in T2D
patients with low initial VO2max have shown larger im-
provements in CRF. For example, improvements in CRF
of 16-25 % were observed after 5 months of IWT [18, 41]
and improvements of the same magnitude (18–46 %) were
demonstrated in other patient groups undergoing high in-
tensity exercise interventions [42, 43]. Therefore, the
IWFT could be used as a tool to evaluate these types of
exercise programs.
We performed a post hoc analysis to assess the relative
validity [38]. The sensitivity and specificity of the pre-
dicted VO2peak values to classify the participants into low/
intermediate and high risk as compared to the observed
VO2peak values were thus calculated. The cut off values
were based on reference values published by Kodoma et
al. [8]. High risk participants were characterized with a
VO2peak <7.9 metabolic equivalents. The sensitivity was
98 % and 94 % for the LP and UP, respectively. The speci-
ficity was 77 % for both positions. Thus, to stratify individ-
uals at risk, the post hoc analysis indicated a similar
performance across body locations. However, the sample
was very homogenous and characterized by poor fitness as
compared to the normal population [12]. In view of the
small sample size, the interpretation of the relative validity
should thus be done with caution.
Strengths and limitations
The main strengths of the study include the direct meas-
urement of VO2peak, the well-characterized sample and
an objective indirect measure of intensity. The validity
and reliability of the IWFT were furthermore tested in a
non-laboratory condition, increasing feasibility of usage
in clinical care and rehabilitation without access to a
laboratory. Finally, the independence of therapist en-
couragement on test performance enables patients to
perform the test by themselves. With the online data
upload the patients’ performance can be monitored over
the distance, enabling use in large scale health surveil-
lance programs as well as decreasing the workload of
clinicians and therapists.
Some limitations to the study need to be addressed.
First, the homogeneity of the sample and the relatively
small sample size could limit the generalizability of the
findings. However, the cross-validation demonstrated
high accuracy and reliability of the equations. Therefore,
we are confident that the equations can be employed in
other populations with similar characteristics without
loss of accuracy. Furthermore, we did not base the sam-
ple size on a formal sample size calculation, thus the
study might have been under powered to detect statisti-
cally significant differences between the predicted and
measured VO2peak values. However, the difference was
very low (<10 ml O2*min
−1), and within the measure-
ment error of the criterion measure Cosmed K4b2
(Cosmed, Italy) [16]. Second, the estimation of VO2 with
accelerometers used during incline walking is not accur-
ate [44]. The IWFT was performed on level surface, thus
limiting the performance of the equations to surfaces
without incline. Third, many studies do indeed observe
an association between e.g. VO2max rather than VO2peak
[8] as predicted by our equations. However, this associ-
ation is still present when using VO2peak as a predictor
[8]. Fourth, due to the short resting period (20 min)
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between the paced and non-paced protocol and the lack
of a randomized order of the administration of the
protocol, fatigue could have prohibited the participants
to reach a higher VO2peak during the paced protocol.
However, no difference in the RER-values was observed
(mean difference [95 % CI] 0.02 [−0.03; 0.07], p = 0.44
between the paced and the non-paced protocols). Thus,
we do not believe that the resting period and the lack of
randomization explains the lack of effect of pacing the
participants during the protocol. Fifth, the IWFT is a
measure of VO2peak during walking and thus might not
be feasible for exercise prescription for other exercise
modalities.
Conclusion
In conclusion the IWFT is a valid and reliable tool in es-
timating VO2peak in persons with similar characteristics
as this sample, i.e. patients with a low VO2max, during
walking. The IWFT displays similar criterion validity as
other commonly used field-based walking tests. In order
to obtain the highest accuracy and precision, the smart-
phone should be placed in the side pocket of the pants.
The fact that no effect of encouragement on test per-
formance was observed with high reliability indicates
that the IWFT is feasible for self-administration as well
as for use in the clinic. With the automatic transmission
of test results, the IWFT makes it possible to test large
groups of people over distance in a time-saving and eco-
nomical manner. The test could give a fair estimate of
the CRF in absence of a progressive maximal test during
standardized conditions with the appropriate equipment.
Abbreviations
6MWT: 6-min walking test; BMI: Body mass index; CI: Confidence interval;
Cm: Centimeter; CRF: Cardio respiratory fitness; EE: Energy expenditure;
HbA1c: Glycolated haemoglobin 1 ac; ICC: Intra class correlation;
IWFT: InterWalk fitness test; IWT: Interval walking training; Kg: Kilogram;
LOA: Limits of agreement; LOOCV: Leave one out cross validation; LP: Lower
position; MD: Mean difference; MDC: Minimal detectable difference;
T2D: Type 2 diabetes; UP: Upper position; VM: Vector magnitude
Acknowledgements
The authors would like to thank the participants for their time. We would
furthermore like to acknowledge the foundations supporting the work. The
study is part of the DD2, acronym for ‘The Danish Centre for Strategic
Research in Type 2 Diabetes’ that is supported by grants from The Danish
Strategic Research Council (grant no. 09–067009 and 09–075724). DD2
funding and partners are listed at www.dd2.nu. The Centre for Physical
Activity Research (CFAS) is supported by a grant from Trygfonden. The
CopenRehab is supported by a grant from the Municipality of Copenhagen.
Furthermore, this study is supported by a postdoc grant from The Danish
Diabetes Academy (supported by the Novo Nordic Foundation) and grants
from the Augustinus Foundation, Fonden for Lægevidenskabens fremme
and Viggo og Krista Pedersens Foundation. Finally, the authors would like to
thank Prof. Lars Bo Andersen for his valuable input to the data analysis and
interpretation.
Availability of data and materials
Data and materials are available upon request. Please contact the corresponding
author.
Authors’ contributions
All authors made substantial contributions to study conception and design
and revised the manuscript critically for important intellectual content and
have given their final approval of the manuscript to be published. CFB and
MR-L drafted the manuscript. CFB, IKT and MR-L collected and processed the
data. MR-L performed the statistical analyses. CFB and MR-L had full access
to all data and takes the full responsibility for data integrity. All read and
approved the final manuscript.
Competing interests
The authors declare no competing interests.
Consent for publication
Consent to publish the image (Fig. 1) was obtained prior to submission.
Ethics approval and consent to participate
Participants received oral and written information about the study and informed
consent was obtained from all participants. The study is approved by the
Regional Ethics Committee of the Capital Region of Denmark (H-1-2013-116).
Author details
1Centre for Physical Activity Research, Finsen Centre, Rigshospitalet,
University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark.
2Department of Endocrinology (Diabetes and Metabolism), Rigshospitalet,
University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark.
3Department of Public Health, Section of Social Medicine, University of
Copenhagen, Henrik Pontoppidans Vej 4, 2200 Copenhagen, Denmark.
4Department of Endocrinology, Odense University Hospital, Sdr. Boulevard
29, Entrance 112, 3rd floor, 5000 Odense, Denmark. 5The Danish Diabetes
Academy, Odense University Hospital, Sdr. Boulevard 29, Entrance 112, 3rd
floor, 5000 Odense, Denmark.
Received: 16 September 2016 Accepted: 28 September 2016
References
1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.
2. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al.
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21
regions, 1990–2010: a systematic analysis for the Global Burden of Disease
Study 2010. Lancet. 2012;380:2197–223.
3. De Cock KM, Simone PM, Davison V, Slutsker L. The new global health.
Emerg Infect Dis. 2013;19:1192–7.
4. Aadahl M, Kjaer M, Kristensen JH, Mollerup B, Jorgensen T. Self-reported
physical activity compared with maximal oxygen uptake in adults. Eur J
Cardiovasc Prev Rehabil. 2007;14:422–8.
5. Garber CE, Blissmer B, Deschenes MR, Franklin BA, LaMonte MJ, Lee IM, et al.
American College of Sports Medicine position stand. Quantity and quality of
exercise for developing and maintaining cardiorespiratory, musculoskeletal,
and neuromotor fitness in apparently healthy adults: guidance for
prescribing exercise. Med Sci Sports Exerc. 2011;43:1334–59.
6. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, et al. The
prognostic value of a nomogram for exercise capacity in women. N Engl J
Med. 2005;353:468–75.
7. Hainer V, Toplak H, Stich V. Fat or fit: what is more important? Diabetes
Care. 2009;32 Suppl 2:S392–7.
8. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al.
Cardiorespiratory fitness as a quantitative predictor of all-cause mortality
and cardiovascular events in healthy men and women: a meta-analysis.
JAMA. 2009;301:2024–35.
9. Mayorga-Vega D, Bocanegra-Parrilla R, Ornelas M, Viciana J. Criterion-Related
Validity of the Distance-and Time-Based Walk/Run Field Tests for Estimating
Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis. PLoS ONE.
2016;11, e0151671.
10. Pollock ML, Carroll JF, Graves JE, Leggett SH, Braith RW, Limacher M, et al.
Injuries and adherence to walk/jog and resistance training programs in the
elderly. Med Sci Sports Exerc. 1991;23:1194–200.
11. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in
chronic disease. Scand J Med Sci Sports. 2006;16 Suppl 1:3–63.
Brinkløv et al. BMC Sports Science, Medicine and Rehabilitation  (2016) 8:31 Page 8 of 9
12. Edvardsen E, Scient C, Hansen BH, Holme IM, Dyrstad SM, Anderssen SA.
Reference values for cardiorespiratory response and fitness on the treadmill
in a 20–to 85–year-old population. Chest. 2013;144:241–8.
13. Ried-Larsen M, Thomsen RW, Berencsi K, Brinkløv CF, Brøns C, Valentiner L,
et al. Implementation of interval walking training in patients with Type 2
diabetes in Denmark; Rationale, design and baseline characteristics. In:
Clinical Epidemiology. 2015.
14. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;
287:2398–9.
15. Haugen HA, Chan LN, Li F. Indirect calorimetry: a practical guide for
clinicians. Nutr Clin Pract. 2007;22:377–88.
16. Pinnington HC, Wong P, Tay J, Green D, Dawson B. The level of accuracy
and agreement in measures of FEO2, FECO2 and VE between the Cosmed
K4b2 portable, respiratory gas analysis system and a metabolic cart. J Sci
Med Sport. 2001;4:324–35.
17. Hausswirth C, Bigard AX, Le Chevalier JM. The Cosmed K4 telemetry system
as an accurate device for oxygen uptake measurements during exercise. Int
J Sports Med. 1997;18:449–53.
18. Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK,
et al. The effects of free-living interval-walking training on glycemic control,
body composition, and physical fitness in type 2 diabetic patients: a
randomized, controlled trial. Diabetes Care. 2013;36:228–36.
19. Brage S, Wedderkopp N, Franks PW, Andersen LB, Froberg K. Reexamination
of validity and reliability of the CSA monitor in walking and running. Med
Sci Sports Exerc. 2003;35:1447–54.
20. Vaha-Ypya H, Vasankari T, Husu P, Manttari A, Vuorimaa T, Suni J, et al.
Validation of Cut-Points for Evaluating the Intensity of Physical Activity
with Accelerometry-Based Mean Amplitude Deviation (MAD). PLoS ONE.
2015;10, e0134813.
21. Vaha-Ypya H, Vasankari T, Husu P, Suni J, Sievanen H. A universal, accurate
intensity-based classification of different physical activities using raw data of
accelerometer. Clin Physiol Funct Imaging. 2015;35:64–70.
22. Yamazaki T, Gen-No H, Kamijo Y, Okazaki K, Masuki S, Nose H. A new device
to estimate VO2 during incline walking by accelerometry and barometry.
Med Sci Sports Exerc. 2009;41:2213–9.
23. Bouchard C, Daw EW, Rice T, Perusse L, Gagnon J, Province MA, et al.
Familial resemblance for VO2max in the sedentary state: the HERITAGE
family study. Med Sci Sports Exerc. 1998;30:252–8.
24. Lee I-M, Blair S, Manson J, Paffenberger RS. Establishing Validity and
Reliability of Physical Activity. In: Epidemiological methods in physical
activity studies. 1st ed. Oxford: Oxford University Press; 2009. p. 34–55.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between
two methods of clinical measurement. Lancet. 1986;1:307–10.
26. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John
Wiley & Sons, Inc; 1986.
27. Jorgensen R, Ris I, Falla D, Juul-Kristensen B. Reliability, construct and
discriminative validity of clinical testing in subjects with and without
chronic neck pain. BMC Musculoskelet Disord. 2014;15:408.
28. De Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus
reliability measures. J Clin Epidemiol. 2006;59:1033–9.
29. Kim DY, Jung YS, Park RW, Joo NS. Different location of triaxial accelerometer
and different energy expenditures. Yonsei Med J. 2014;55:1145–51.
30. Swartz AM, Strath SJ, Bassett Jr DR, O’Brien WL, King GA, Ainsworth BE.
Estimation of energy expenditure using CSA accelerometers at hip and
wrist sites. Med Sci Sports Exerc. 2000;32:S450–6.
31. Yngve A, Nilsson A, Sjostrom M, Ekelund U. Effect of monitor placement
and of activity setting on the MTI accelerometer output. Med Sci Sports
Exerc. 2003;35:320–6.
32. Kervio G, Carre F, Ville NS. Reliability and intensity of the 6-min walk test in
healthy elderly subjects. Med Sci Sports Exerc. 2003;35:169–74.
33. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW,
et al. The 6-min walk: a new measure of exercise capacity in patients with
chronic heart failure. Can Med Assoc J. 1985;132:919–23.
34. Aadahl M, Zacho M, Linneberg A, Thuesen BH, Jorgensen T. Comparison
of the Danish step test and the watt-max test for estimation of
maximal oxygen uptake: the Health2008 study. Eur J Prev Cardiol.
2013;20:1088–94.
35. Troosters T, Gosselink R, Decramer M. Six minute walking distance in
healthy elderly subjects. Eur Respir J. 1999;14:270–4.
36. Jenkins S, Cecins NM. Six-minute walk test in pulmonary rehabilitation: do
all patients need a practice test? Respirology. 2010;15:1192–6.
37. Osadnik CR, Borges RC, McDonald CF, Carvalho CR, Holland AE. Two 6-
minute Walk Tests Are Required during Hospitalisation for Acute
Exacerbation of COPD. COPD. 2015;7:1–5.
38. Kelly P, Fitzsimons C, Baker G. Should we reframe how we think about
physical activity and sedentary behaviour measurement? Validity and
reliability reconsidered. Int J Behav Nutr Phys Act. 2016;13:32.
39. Billat V, Demarle A, Paiva M, Koralsztein JP. Effect of training on the
physiological factors of performance in elite marathon runners (males and
females). Int J Sports Med. 2002;23:336–41.
40. Breil FA, Weber SN, Koller S, Hoppeler H, Vogt M. Block training
periodization in alpine skiing: effects of 11-day HIT on VO2max and
performance. Eur J Appl Physiol. 2010;109:1077–86.
41. Jakicic JM, Jaramillo SA, Balasubramanyam A, Bancroft B, Curtis JM, Mathews
A, et al. Effect of a lifestyle intervention on change in cardiorespiratory
fitness in adults with type 2 diabetes: results from the Look AHEAD Study.
Int J Obes (Lond). 2009;33:305–16.
42. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM,
et al. Superior cardiovascular effect of aerobic interval training versus
moderate continuous training in heart failure patients: a randomized study.
Circulation. 2007;115:3086–94.
43. Rognmo O, Hetland E, Helgerud J, Hoff J, Slordahl SA. High intensity aerobic
interval exercise is superior to moderate intensity exercise for increasing
aerobic capacity in patients with coronary artery disease. Eur J Cardiovasc
Prev Rehabil. 2004;11:216–22.
44. Terrier P, Aminian K, Schutz Y. Can accelerometry accurately predict the
energy cost of uphill/downhill walking? Ergonomics. 2001;44:48–62.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Brinkløv et al. BMC Sports Science, Medicine and Rehabilitation  (2016) 8:31 Page 9 of 9
